Transcranial Magnetic Stimulation (TMS) trials

rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

RecruitingNCT05671185Phase: NAStarted 2022-12-01

Summary

Around 40% of schizophrenia patients present depressive symptoms, which are associated with elevated suicide and violence risk and poor prognosis and quality of life. Recent meta-analysis showed the e

Eligibility

Sex
ALL
Min Age
20 Years
Max Age
None

Locations

Department of Psychiatry, National Taiwan University HospitaDouliu, Yunlin, Taiwan

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT05671185